Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Investigate safety, tolerability and pharmacokinetics of CP-751,871 when given in combination
with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer